GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,392.50p
   
  • Change Today:
      2.00p
  • 52 Week High: 1,671.00p
  • 52 Week Low: 1,264.00p
  • Currency: UK Pounds
  • Shares Issued: 4,080.57m
  • Volume: 4,945,221
  • Market Cap: £56,822m
  • RiskGrade: 129

Latest ShareCast News

London close: FTSE finishes week just shy of 9,000

By Josh White

Date: Friday 18 Jul 2025

(Sharecast News) - London stocks ended higher on Friday, supported by a positive shift in investor sentiment following US consumer confidence data.

GSK Regulatory News

Transaction in Own Shares 25-Jul-2025 07:00 RNS
Blenrep approved in the EU for multiple myeloma 24-Jul-2025 17:00 RNS
Transaction in Own Shares 24-Jul-2025 07:00 RNS
US FDA review extended for Blenrep 23-Jul-2025 17:00 RNS
Transaction in Own Shares 23-Jul-2025 07:00 RNS

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GSK Market Data

Currency UK Pounds
Share Price 1,392.50p
Change Today 2.00p
% Change 0.14 %
52 Week High 1,671.00p
52 Week Low 1,264.00p
Volume 4,945,221
Shares Issued 4,080.57m
Market Cap £56,822m
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
29.36% below the market average29.36% below the market average29.36% below the market average29.36% below the market average29.36% below the market average
46.67% above the sector average46.67% above the sector average46.67% above the sector average46.67% above the sector average46.67% above the sector average
Price Trend
14.69% below the market average14.69% below the market average14.69% below the market average14.69% below the market average14.69% below the market average
46.67% above the sector average46.67% above the sector average46.67% above the sector average46.67% above the sector average46.67% above the sector average
Income
79.44% above the market average79.44% above the market average79.44% above the market average79.44% above the market average79.44% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Growth
29.77% below the market average29.77% below the market average29.77% below the market average29.77% below the market average29.77% below the market average
54.84% below the sector average54.84% below the sector average54.84% below the sector average54.84% below the sector average54.84% below the sector average

What The Brokers Say

Strong Buy 3
Buy 2
Neutral 15
Sell 3
Strong Sell 0
Total 23
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q1 Q4
Ex-Div 15-May-25 20-Feb-25
Paid 10-Jul-25 10-Apr-25
Amount 16.00p 16.00p

Trades for 25-Jul-2025

Time Volume / Share Price
16:01 51 @ 1,393.50p
15:52 27 @ 1,394.00p
16:07 0 @ 1,393.50p
16:07 0 @ 1,393.50p
16:07 0 @ 1,393.50p

GSK Key Personnel

CEO Emma Walmsley

Top of Page